These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15147446

  • 1. Cytotoxic mechanisms in different forms of T-cell-mediated drug allergies.
    Kuechler PC, Britschgi M, Schmid S, Hari Y, Grabscheid B, Pichler WJ.
    Allergy; 2004 Jun; 59(6):613-22. PubMed ID: 15147446
    [Abstract] [Full Text] [Related]

  • 2. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH.
    J Immunol; 1998 Oct 15; 161(8):3957-65. PubMed ID: 9780164
    [Abstract] [Full Text] [Related]

  • 3. Cytolytic capabilities of lamina propria and intraepithelial lymphocytes in normal and chronically inflamed human intestine.
    Melgar S, Hammarström S, Oberg A, Danielsson A, Hammarström ML.
    Scand J Immunol; 2004 Oct 15; 60(1-2):167-77. PubMed ID: 15238086
    [Abstract] [Full Text] [Related]

  • 4. KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
    Suck G, Branch DR, Smyth MJ, Miller RG, Vergidis J, Fahim S, Keating A.
    Exp Hematol; 2005 Oct 15; 33(10):1160-71. PubMed ID: 16219538
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K, Takahashi T, Iwase S, Matsudaira Y, Kaneko Y, Yagita H, Obata Y.
    J Immunol; 1998 Jun 01; 160(11):5253-61. PubMed ID: 9605121
    [Abstract] [Full Text] [Related]

  • 7. Antiestrogens affect both pathways of killer cell-mediated oncolysis.
    Haeryfar SM, Nagy E, Baral E, Krepart G, Lotocki R, Berczi I.
    Anticancer Res; 2000 Jun 01; 20(3A):1849-53. PubMed ID: 10928117
    [Abstract] [Full Text] [Related]

  • 8. Cell-mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura.
    Zhang F, Chu X, Wang L, Zhu Y, Li L, Ma D, Peng J, Hou M.
    Eur J Haematol; 2006 May 01; 76(5):427-31. PubMed ID: 16480433
    [Abstract] [Full Text] [Related]

  • 9. Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection.
    Zelinskyy G, Balkow S, Schimmer S, Schepers K, Simon MM, Dittmer U.
    Virology; 2004 Dec 20; 330(2):365-74. PubMed ID: 15567431
    [Abstract] [Full Text] [Related]

  • 10. Fas-mediated cytotoxicity remains intact in perforin and granzyme B antisense transfectants of a human NK-like cell line.
    Montel AH, Bochan MR, Goebel WS, Brahmi Z.
    Cell Immunol; 1995 Oct 15; 165(2):312-7. PubMed ID: 7553897
    [Abstract] [Full Text] [Related]

  • 11. Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL.
    Ando K, Hiroishi K, Kaneko T, Moriyama T, Muto Y, Kayagaki N, Yagita H, Okumura K, Imawari M.
    J Immunol; 1997 Jun 01; 158(11):5283-91. PubMed ID: 9164947
    [Abstract] [Full Text] [Related]

  • 12. Neem leaf glycoprotein induces perforin-mediated tumor cell killing by T and NK cells through differential regulation of IFNgamma signaling.
    Bose A, Chakraborty K, Sarkar K, Goswami S, Chakraborty T, Pal S, Baral R.
    J Immunother; 2009 Jan 01; 32(1):42-53. PubMed ID: 19307993
    [Abstract] [Full Text] [Related]

  • 13. Perforin-mediated lysis of tumor cells by Mycobacterium bovis Bacillus Calmette-Guérin-activated killer cells.
    Brandau S, Suttmann H, Riemensberger J, Seitzer U, Arnold J, Durek C, Jocham D, Flad HD, Böhle A.
    Clin Cancer Res; 2000 Sep 01; 6(9):3729-38. PubMed ID: 10999767
    [Abstract] [Full Text] [Related]

  • 14. Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis.
    Vergelli M, Hemmer B, Muraro PA, Tranquill L, Biddison WE, Sarin A, McFarland HF, Martin R.
    J Immunol; 1997 Mar 15; 158(6):2756-61. PubMed ID: 9058810
    [Abstract] [Full Text] [Related]

  • 15. Dimethyl 2,2-dichlorovinyl phosphate (DDVP) markedly inhibits activities of natural killer cells, cytotoxic T lymphocytes and lymphokine-activated killer cells via the Fas-ligand/Fas pathway in perforin-knockout (PKO) mice.
    Li Q, Nakadai A, Takeda K, Kawada T.
    Toxicology; 2004 Nov 01; 204(1):41-50. PubMed ID: 15369847
    [Abstract] [Full Text] [Related]

  • 16. An anergic cytotoxic T lymphocyte clone exhibits granule exocytosis-mediated cytotoxicity.
    Kuwano K, Akashi A, Arai S.
    Cell Immunol; 1998 May 01; 185(2):114-22. PubMed ID: 9636689
    [Abstract] [Full Text] [Related]

  • 17. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M, Ohminami H, Yakushijin Y, Arai J, Hasegawa A, Ishida Y, Fujita S.
    J Immunol; 1999 May 15; 162(10):6100-6. PubMed ID: 10229852
    [Abstract] [Full Text] [Related]

  • 18. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 19. The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment.
    Guillot B, Portalès P, Thanh AD, Merlet S, Dereure O, Clot J, Corbeau P.
    Br J Dermatol; 2005 Apr 01; 152(4):690-6. PubMed ID: 15840100
    [Abstract] [Full Text] [Related]

  • 20. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z, Shatry A, Deyev V, Podack E, Mammolenti M, Blazar BR, Yagita H, Levy RB.
    Biol Blood Marrow Transplant; 2005 Aug 01; 11(8):576-86. PubMed ID: 16041307
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.